Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Strong earnings forecasts, miners lift FTSE 100 to 3-week highs

Published 07/12/2021, 08:49
Updated 07/12/2021, 17:35
© Reuters. FILE PHOTO: Pedestrians leave and enter the London Stock Exchange in London, Britain August 15, 2017. REUTERS/Neil Hall/File Photo

© Reuters. FILE PHOTO: Pedestrians leave and enter the London Stock Exchange in London, Britain August 15, 2017. REUTERS/Neil Hall/File Photo

By Bansari Mayur Kamdar

(Reuters) -UK's FTSE 100 rose to a three-week highs on Tuesday, boosted by mining stocks and positive earnings outlooks, with global markets taking relief from receding concerns about the Omicron variant of the coronavirus.

The commodity-heavy FTSE 100 ended 1.5% higher with base metal miners leading gains as copper prices were boosted by monetary policy easing in top consumer China. [MET/L]

Plumbing parts distributor Ferguson advanced 5.9% and was among the top gainers on the index after a strong revenue growth forecast.

Rental equipment provider Ashtead Group (LON:AHT) PLC rose 3.9% after raising dividend and saying it expects full-year results ahead of previous estimates.

"Ferguson spun-off its UK-based operation Wolseley (LON:FERG), so it's now just a U.S.-based company, and Ashtead also has a very big presence in the U.S.," said Michael Hewson, chief markets analyst at CMC Markets.

"They're essentially leveraging a decent recovery in the U.S. economy and that's why they are posting decent gains."

The FTSE 100 has rebounded to levels touched before the detection of the Omicron variant in late November after experts said the new strain might not be as severe as feared.

The domestically focussed mid-cap index advanced 1.6%, with travel and leisure stocks recovering 1.2% after getting hammered recently on fears of tighter travel restrictions.

British American Tobacco (LON:BATS) gained 1.0% after reiterating its full-year profit and sales forecasts, as more people switched to its Vuse vaping and Velo oral nicotine products.

© Reuters. FILE PHOTO: Pedestrians leave and enter the London Stock Exchange in London, Britain August 15, 2017. REUTERS/Neil Hall/File Photo

"It's just a start but, given the regulatory, investor and political pressure associated with the sale of traditional cigarettes it is a modest step in the right direction for the business," said Russ Mould, investment director at AJ Bell.

Heavyweight drugmaker AstraZeneca (NASDAQ:AZN) declined 1.7% after brokerage Jefferies downgraded the stock saying its earnings per share is set to decline to single-digit growth beyond 2026.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.